Caractérisation du transport moléculaire vésical : applications cliniques et pharmacologiques

Caractérisation du transport moléculaire vésical : applications cliniques et pharmacologiques

Show other versions (1)

Les pathologies vésicales sont nombreuses et nécessitent la plupart du temps un traitement médicamenteux. Il peut alors être administré par voie intravésicale, augmentant son efficience et limitant les effets indésirables systémiques. Nous nous sommes intéressés à quatre thérapeutiques : l’alun de p...

Full description

Bibliographic Details
Main Author:	Moch, Céline
Other Authors:	Lyon 1
Language:	fr
Published:	2014
Subjects:	Alun de potassium Lidocaïne Méthylprednisolone Mitomycine C BCG Vessie Perméation Culture cellulaire Potassium alum Lidocaine Methylprednisolone Mitomycin C Bladder Permeation Culture cell 615
Online Access:	http://www.theses.fr/2014LYO10013/document

Similar Items

Caractérisation du transport moléculaire vésical : applications cliniques et pharmacologiques
by: Moch, Céline
Published: (2014)

Intratympanic methylprednisolone acetate versus intratympanic lidocaine in the treatment of idiopathic subjective unilateral tinnitus of less than 1-year duration: a randomized, double-blind, clinical trial
by: Diaa El Din M. El Hennawi, et al.
Published: (2017-07-01)

Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids
by: Taskovska Milena, et al.
Published: (2020-05-01)

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
by: Stefanie Schmidt, et al.
Published: (2020-07-01)

The Efficacy of Local Injection of Methylprednisolone and Lidocaine with and Without Splint, in Treating Patients with De Quervain's Tenosynovitis
by: Saleh, et al.
Published: (2012-02-01)

The effect of subcutaneous injection of methylprednisolone acetate and lidocaine for refractory postherpetic neuralgia: a prospective, observational study
by: Duc Thuan Nguyen, et al.
Published: (2021-06-01)

Facteurs prédictifs de l'issue de l'immunothérapie au BCG des tumeurs superficielles de la vessie
by: Decobert, Marc
Published: (2007)

Original paper <br> Strength of contraction in isolated bladder strips of rats: effect of chemotherapeutic agents mitomycin C and farmorubicin
by: Dirk P.J. Michielsen, et al.
Published: (2005-09-01)

Aggregation properties of triamcinolone acetonide injection in human serum: considerations when performing epidural steroid injections
by: Wahezi SE, et al.
Published: (2019-03-01)

Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists
by: Miguel Unda-Urzáiz, et al.
Published: (2018-09-01)

The Effect of Adding an Initial Dose of Mitomycin C into the Ve-sicular Delayed Six-Week Treatment in Patients with Superficial Bladder Cancer
by: Farhad Tadayyon, et al.
Published: (2011-03-01)

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
by: Marco Racioppi, et al.
Published: (2018-12-01)

Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation
by: Omar MM, et al.
Published: (2019-02-01)

MITOMYCIN C METABOLISM AND INTERACTION WITH SULFUR NUCLEOPHILES IN BONE MARROW, DNA, AND CLONOGENIC TUMOR CELLS (ANTICANCER, ANTIBIOTIC).
by: Dorr, Robert Thomas
Published: (1984)

Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study
by: Devendra Maheshwari, et al.
Published: (2020-01-01)

Methods for direct determination of mitomycin C in aqueous solutions and in urine
by: Palecek Emil, et al.
Published: (1998-01-01)

Studies towards enantioselective synthesis of mitomycins
by: Gu, Qiangshuai, et al.
Published: (2015)

BCG-THERAPIE ET CANCER DE LA VESSIE : LA CARACTERISATION ET LA MODELISATION DE LA REPONSE IMMUNE AU BCG DANS LA VESSIE REVELENT DES STRATEGIES POUR L'AMELIORATION DE LA REPONSE ANTI-TUMORALE
by: Biot, Claire
Published: (2012)

Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA)
by: Bor Kos, et al.
Published: (2016-08-01)

Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer
by: Ali Serdar Gözen, et al.
Published: (2017-06-01)

Effect of Perioperative Lidocaine, Propofol and Steroids on Pulmonary Metastasis in a Murine Model of Breast Cancer Surgery
by: James Freeman, et al.
Published: (2019-05-01)

Geschlechts-chromosomale Kopplung der Fanconi Anämie Gene FANCC und FANCG im Hühnergenom und die geschlechtsspezifische Sensibilität der Hühnerzellen gegenüber Mitomycin C
by: Buwe, Andrea
Published: (2013)

Iatrogenic Stenosis of Anterior Nares: A Case Report
by: Arunkumar J.S., et al.
Published: (2014-04-01)

Cytomorphological Effects of Mitomycin C on Urothelial Cells: Eosinophils May Be Clue to The Drug-Induced Changes
by: Gulcin Guler Simsek, et al.
Published: (2014-04-01)

Clinical observation of glaucoma trabeculectomy with mitomycin C treatment
by: Shi Liu, et al.
Published: (2014-12-01)

Our results of large area mitomycin C application trabeculectomy in cases with advanced glaucoma
by: Mutlu Cihan Dağlıoğlu, et al.
Published: (2013-12-01)

Comparative study of pterygium surgery combined with bevacizumab or mitomycin C
by: Qi-Bin Xu, et al.
Published: (2013-12-01)

Low dose Mitomycin-C in severe vernal keratoconjunctivitis: A randomized prospective double blind study
by: Jain Arun, et al.
Published: (2006-01-01)

Topical mitomycin-C for treatment of laryngotracheal stenosis after the treatment with laser and dilatation
by: Dabirmoghadam P, et al.
Published: (2010-01-01)

LEGAL BASIC OF BCG-THERAPY FOR BLADDER CANCER IN MUNICIPAL POLYCLINICS
by: M. M. Zorina, et al.
Published: (2016-10-01)

Nasal endoscope combined with Nd:YAG laser for recurrent dacryocystitis
by: Li-Shan Yang, et al.
Published: (2014-08-01)

Effects of glucocorticoid immunosuppression on serum cystatin C levels
by: Gruev Todor, et al.
Published: (2009-01-01)

Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
by: Sabrina Trigo, et al.
Published: (2021-03-01)

Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C
by: Andrew T. Lenis, et al.
Published: (2018-10-01)

Reconstruction d'un modèle vésical par génie tissulaire et caractérisation
by: Bouhout, Sara
Published: (2015)

Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma:retrospective review
by: Zeynep Aktas, et al.
Published: (2014-02-01)

Mitomicina c en la esclerectomía profunda no perforante Mitomycin C in non-penetrating deep sclerostomy
by: Francisco García González, et al.
Published: (1999-12-01)

LASEK con mitomicina C en altos defectos refractivos miópicos Use of LASEK with Mitomycin C to treat high myopic defects
by: Abel Cabrera Martínez, et al.
Published: (2009-12-01)

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01)

Transconjunctival penetration of mitomycin C
by: Velpandian T, et al.
Published: (2008-01-01)

Cannot write session to /tmp/vufind_sessions/sess_gmu3n3kcbm04vc0ds32jvgc8g1